NSG Bio, a leading provider of flexible and high-quality biotech laboratory spaces, has announced the launch of its latest product, NSG BioSuites, located at the brand-new Geneo development in Singapore Science Park. This marks NSG Bio's fourth site in Singapore and also its largest facility to date, representing a significant step forward in providing innovative, accessible solutions for the biotech community.
NSG BioSuites is the company's newest offering: small to large, affordable private lab suites purpose-built for biotech teams ready to scale without compromise. The facility is BSL-2 certified and designed to support both biology and chemistry labs, ensuring flexibility for diverse scientific workflows. With its affordable and flexible options, NSG BioSuites lowers the barriers for biotech companies of all sizes to access world-class laboratory infrastructure.
The fully fitted facility at Geneo includes:
NSG BioSuites is designed not simply as a place to work, but as an incubator and accelerator where biotech companies can spearhead their research and breakthroughs.
"Our mission has always been to make high-quality biotech space more accessible, while empowering companies with the tools, networks, and collaborations needed to thrive," said Daphne Teo, Chairwoman of Board and Founder of NSG Bio. "NSG BioSuites at Geneo reflects this vision by combining state-of-the-art facilities with a vibrant community that supports scientific and business success."
